Elrod James W 4/A
4/A · KING PHARMACEUTICALS INC · Filed Jan 20, 2011
Insider Transaction Report
Form 4/AAmended
Elrod James W
Chief Legal Officer, Secretary
Transactions
- Award
Common Stock
2011-01-07+17,540→ 207,448 total
Footnotes (2)
- [F1]Reflects shares of common stock earned in connection with Long Term Performance Units (Three-Year Cycle) awarded under the King Pharmaceuticals, Inc. Incentive Plan on March 25, 2008.
- [F2]This amended Form 4 corrects the inadvertent omission from the original statement of certain shares and vested Long-Term Performance Units beneficially owned by the reporting person following this reported transaction.